Sector ratings Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 2025-12-12			5-day change	1st Jan Change
186,800.00 ^KRW	+0.05%		+1.91%	+3.61%

Dec. 11	Celltrion USA, Inc. announced that it expects to receive $532.1 million in funding from Celltrion, Inc.	CI
Dec. 10	Celltrion, Inc. announces Annual dividend	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
CELLTRION, INC.	27.66B		A
LONZA GROUP AG	45.43B		AAA
IQVIA HOLDINGS INC.	37.85B		AAA
BEONE MEDICINES AG	35.31B		-
MEDPACE HOLDINGS, INC.	15.72B		BBB
REVOLUTION MEDICINES, INC.	15.26B	-	B	-		-
ICON PUBLIC LIMITED COMPANY	14.25B		AA
ASCENDIS PHARMA A/S	13.47B	-	-	-		-
IONIS PHARMACEUTICALS, INC.	13.09B	-	A	-		-
TEMPUS AI, INC.	12.56B	-	A	-		-
EUROFINS SCIENTIFIC SE	11.99B		AA
QIAGEN N.V.	9.81B		AAA
ABIVAX	9.6B	-	BBB	-		-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	9.5B		A
BIO-TECHNE CORPORATION	9.12B		A
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	8.21B	-	-	-	-	-	-	-
KYMERA THERAPEUTICS, INC.	7.17B	-	BBB	-		-
PHARMARON BEIJING CO., LTD.	7.11B		AA
PRAXIS PRECISION MEDICINES, INC.	6.72B	-	B	-		-
Average	15.91B		A
Weighted average by Cap.			A